ArticleJournal of cancer survivorship : research and practice2026
Understanding nonresponse and strategies to improve response rates in a randomized controlled trial among breast cancer survivors: the FASTRACS-INSIGHT mixed-methods study.
Article in Journal of cancer survivorship : research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeFASTRACS-RCT is a prospective, multisite, randomized, and controlled trial (N=431). It evaluates the effectiveness of the FASTRACS intervention on the return to work for breast cancer survivors (BCSs). A decrease in the rate of response to the intervention was observed during follow-up. This study aimed to identify reasons for nonresponse and evaluate the acceptability of strategies to improve responses through the INSIGHT (Identify Nonresponse and Strategies to Improve Questionnaires' Trustworthiness) intervention, focusing on BCSs' needs and sustainable response strategies.
methodsNeeds assessment (1): A statistical analysis identified subgroups at higher risk of nonresponse within the FASTRACS-RCT, and individual interviews explored barriers and facilitators to participation. Intervention development and implementation (2): A brainstorming session was conducted with BCSs from the FASTRACS Intersectoral Strategic Participatory Committee (ISPC) and phone calls were made to interview participants. Evaluation (3): A before-and-after analysis of response rates was conducted.
results(1) Nonrespondents were younger than respondents and reported more systemic side effects from breast cancer treatment. Nonresponse was influenced by the breast cancer experience, questionnaire design, and completion context (hospital versus home). (2) Four intervention components were developed: personalized reminder cards with tea bags, printed questionnaires for every participant, a medical appointments booklet with a FASTRACS pen, and reinforcement of phone completion and text reminders. (3) Response rates increased from 54.4% to 74.4% at T3 (p < 0.001) and from 46.2% to 76.7% at T4 (p < 0.001).
conclusionsThe FASTRACS-INSIGHT intervention was developed and implemented, leading to a successful rise in questionnaire completion. IMPLICATIONS FOR CANCER SURVIVORS: The inclusion of BCSs in the development of the FASTRACS-INSIGHT intervention demonstrates the importance of involving BCSs to develop interventions tailored to their needs.
Indexed as
Identifiers
42771283What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.